Alison C. Tree

Primary Endpoint Analyse of the Fase 2-DESTINATION-MRL Trial for Patiënten met Intermediate-Risico Prostaatkanker

Stereotactic Body Radiotherapie for Oligoprogressive Disease in Androgen-Suppressed Prostaatkanker: Primary Endpoint Analyse of the TRAP Trial